Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Menorrhagia × Megestrol Acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 5 Neoplasms 2 Weight Loss 1 Prosthesis Failure 1 Overweight 1 Obesity 1 Nutrition Disorders 1 Menorrhagia 1 Leiomyoma 1 Infertility 1 Hematologic Neoplasms 1 Endometrial Hyperplasia 1 Anorexia 1 Adrenocortical Carcinoma 1

Interventions

relugolix 1 Uterine Myomectomy 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671548 2026-02-02

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡